![NPHCDA on X: "Q: How many doses of COVID-19 vaccines are currently recommended in Nigeria? A: Most brands of COVID-19 vaccine require two doses with varying intervals between the doses. https://t.co/XHgvaj8ckQ" / NPHCDA on X: "Q: How many doses of COVID-19 vaccines are currently recommended in Nigeria? A: Most brands of COVID-19 vaccine require two doses with varying intervals between the doses. https://t.co/XHgvaj8ckQ" /](https://pbs.twimg.com/media/FLTCxvdXIBcv35O.jpg)
NPHCDA on X: "Q: How many doses of COVID-19 vaccines are currently recommended in Nigeria? A: Most brands of COVID-19 vaccine require two doses with varying intervals between the doses. https://t.co/XHgvaj8ckQ" /
![CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota](https://www.childrensmn.org/assets/img/covid19-vac-schedule-chart-01.png)
CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota
![Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines | Nature Communications Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-024-45334-8/MediaObjects/41467_2024_45334_Fig1_HTML.png)
Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines | Nature Communications
![Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study - The Lancet Infectious Diseases Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/57e8bb51-b52f-4ed2-877c-1f702c8f9e3b/gr1.jpg)
Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study - The Lancet Infectious Diseases
![Time intervals used for classifying timeliness of vaccination doses... | Download Scientific Diagram Time intervals used for classifying timeliness of vaccination doses... | Download Scientific Diagram](https://www.researchgate.net/publication/330606299/figure/fig3/AS:718786911010817@1548383562049/Time-intervals-used-for-classifying-timeliness-of-vaccination-doses-received-by-surveyed.png)
Time intervals used for classifying timeliness of vaccination doses... | Download Scientific Diagram
![Guidelines for Adult Immunisation | General Advice – Malaysian Society of Infectious Diseases & Chemotherapy Guidelines for Adult Immunisation | General Advice – Malaysian Society of Infectious Diseases & Chemotherapy](https://adultimmunisation.msidc.my/wp-content/uploads/2020/12/Table-1.1-959x1024.jpg)